$ODYY
Odyssey Group of Companies

2022 Q4 Form 10-Q Financial Statement

#000168316822008426 Filed on December 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2021 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $354.2K $322.5K
YoY Change 9.83%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $354.2K $322.5K
YoY Change 9.83%
Operating Profit -$2.078M -$1.429M
YoY Change 45.36%
Interest Expense $71.30K $216.9K
YoY Change -67.12%
% of Operating Profit
Other Income/Expense, Net -$474.00
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$2.150M -$1.646M
YoY Change 30.57%
Net Earnings / Revenue
Basic Earnings Per Share -$0.03 -$0.02
Diluted Earnings Per Share -$0.03 -$0.02
COMMON SHARES
Basic Shares Outstanding 71.99M shares 88.06M shares
Diluted Shares Outstanding 80.89M shares 88.06M shares

Balance Sheet

Concept 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $50.50K $471.1K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $817.2K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $50.54K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $817.2K
Total Long-Term Assets $50.54K
Total Assets $867.7K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.374M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.252M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.252M
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$56.33M
YoY Change
Common Stock $72.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.384M -$2.996M
YoY Change
Total Liabilities & Shareholders Equity $867.7K
YoY Change

Cashflow Statement

Concept 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$2.150M -$1.646M
YoY Change 30.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$284.7K -$1.165M
YoY Change -75.57%
INVESTING ACTIVITIES
Capital Expenditures $8.038K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.038K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $270.7K $1.080M
YoY Change -74.93%
NET CHANGE
Cash From Operating Activities -$284.7K -$1.165M
Cash From Investing Activities -$8.038K $0.00
Cash From Financing Activities $270.7K $1.080M
Net Change In Cash -$22.04K -$85.44K
YoY Change -74.21%
FREE CASH FLOW
Cash From Operating Activities -$284.7K -$1.165M
Capital Expenditures $8.038K $0.00
Free Cash Flow -$292.7K -$1.165M
YoY Change -74.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001626644
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
354215 usd
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2022Q4 ODYY Common Stock Issued In Debt Financing
CommonStockIssuedInDebtFinancing
usd
CY2022Q4 ODYY Return Of Reserved Shares
ReturnOfReservedShares
usd
CY2021Q4 ODYY Return Of Reserved Shares
ReturnOfReservedShares
usd
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-10-31
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
000-56196
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
Odyssey Health, Inc.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1022125
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
2300 West Sahara Avenue
CY2022Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800 - #4012
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89102
CY2022Q4 dei City Area Code
CityAreaCode
(702)
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
780-6559
CY2022Q4 dei Security12b Title
Security12bTitle
Common Stock ($0.001 par value)
CY2022Q4 dei Trading Symbol
TradingSymbol
ODYY
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75594154 shares
CY2022Q4 us-gaap Cash
Cash
50499 usd
CY2022Q3 us-gaap Cash
Cash
72534 usd
CY2022Q4 ODYY Research And Development Rebate Due From Australian Government
ResearchAndDevelopmentRebateDueFromAustralianGovernment
678800 usd
CY2022Q3 ODYY Research And Development Rebate Due From Australian Government
ResearchAndDevelopmentRebateDueFromAustralianGovernment
366475 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
87880 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
87408 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
817179 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
526417 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2714 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1960 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50544 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43260 usd
CY2022Q4 us-gaap Assets
Assets
867723 usd
CY2022Q3 us-gaap Assets
Assets
569677 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2373652 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1549568 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1009975 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
896700 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
112876 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
110063 usd
CY2022Q4 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
1125026 usd
CY2022Q3 us-gaap Assets Sold Under Agreements To Repurchase Repurchase Liability
AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability
1125026 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
125000 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
125000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
95009 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
48063 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1504991 usd
CY2022Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1406937 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6251520 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5213294 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71994154 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71994154 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77860563 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77860563 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
71995 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
77861 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
50871742 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49456476 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56327534 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54177954 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5383797 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4643617 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
867723 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
569677 usd
CY2021Q4 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
322504 usd
CY2022Q4 ODYY Asset Purchase Liability
AssetPurchaseLiability
0 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1723589 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1106884 usd
CY2021Q4 ODYY Asset Purchase Liability
AssetPurchaseLiability
-1936 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2077804 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1429388 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
71302 usd
CY2021Q4 us-gaap Interest Expense
InterestExpense
216886 usd
CY2022Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
474 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2149580 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1646274 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80891387 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88064376 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80891387 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88064376 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4643617 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1168690 usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
240710 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2149580 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5383797 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-2767353 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
533105 usd
CY2021Q4 ODYY Common Stock Issued In Debt Financing
CommonStockIssuedInDebtFinancing
17718 usd
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
867035 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1646274 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2995769 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2149580 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1646274 usd
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
754 usd
CY2021Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
138 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1168690 usd
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
533105 usd
CY2022Q4 ODYY Common Stock Issued For Debt Financing Commitment Shares
CommonStockIssuedForDebtFinancingCommitmentShares
0 usd
CY2021Q4 ODYY Common Stock Issued For Debt Financing Commitment Shares
CommonStockIssuedForDebtFinancingCommitmentShares
17718 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
68054 usd
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
166940 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
472 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
142653 usd
CY2022Q4 ODYY Increase Decrease In Research And Development Rebate Due
IncreaseDecreaseInResearchAndDevelopmentRebateDue
312325 usd
CY2021Q4 ODYY Increase Decrease In Research And Development Rebate Due
IncreaseDecreaseInResearchAndDevelopmentRebateDue
264209 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
824084 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
143810 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
113275 usd
CY2021Q4 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-3719 usd
CY2022Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2813 usd
CY2021Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
31870 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-284707 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1165210 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8038 usd
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8038 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
30000 usd
CY2021Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
250000 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
CY2021Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
37269 usd
CY2022Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
240710 usd
CY2021Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
867035 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
270710 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1079766 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-22035 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-85444 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72534 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
556584 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50499 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
471140 usd
CY2022Q4 ODYY Increase In Principal Of Notes Payable
IncreaseInPrincipalOfNotesPayable
115000 usd
CY2021Q4 ODYY Increase In Principal Of Notes Payable
IncreaseInPrincipalOfNotesPayable
0 usd
CY2022Q4 ODYY Shares Returned To Treasury
SharesReturnedToTreasury
8800 usd
CY2021Q4 ODYY Shares Returned To Treasury
SharesReturnedToTreasury
0 usd
CY2022Q4 ODYY Common Stock Issued For Debt Financing Commitment Shares
CommonStockIssuedForDebtFinancingCommitmentShares
0 usd
CY2021Q4 ODYY Common Stock Issued For Debt Financing Commitment Shares
CommonStockIssuedForDebtFinancingCommitmentShares
17718 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56327534 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50499 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
3250000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.29
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
50000 shares
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
754 usd
CY2021Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
138 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
2664 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
3550 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
3550 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
3550 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
3550 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
33680 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50544 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1725000 usd
CY2022Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1580000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1725000 usd
CY2022Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1580000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.50
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9845000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.40
CY2022Q4 us-gaap Notes Payable
NotesPayable
1725000 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
1580000 usd
CY2022Q4 ODYY Unamortized Debt Discount And Closing Costs
UnamortizedDebtDiscountAndClosingCosts
95009 usd
CY2022Q3 ODYY Unamortized Debt Discount And Closing Costs
UnamortizedDebtDiscountAndClosingCosts
48063 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1629991 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1531937 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6645000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.46
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1826450 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y2M12D
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26944955 shares
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8981749 shares
CY2022Q4 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
663436 usd
CY2022Q4 ODYY Research And Development Rebate
ResearchAndDevelopmentRebate
322671 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
29161 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
3387 usd
CY2022Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
919848 usd
CY2022Q3 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
820771 usd

Files In Submission

Name View Source Status
0001683168-22-008426-index-headers.html Edgar Link pending
0001683168-22-008426-index.html Edgar Link pending
0001683168-22-008426.txt Edgar Link pending
0001683168-22-008426-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
odyy-20221031.xsd Edgar Link pending
odyy_ex1004.htm Edgar Link pending
odyy_ex1005.htm Edgar Link pending
odyy-20221031_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
odyy-20221031_def.xml Edgar Link unprocessable
odyy-20221031_lab.xml Edgar Link unprocessable
odyy-20221031_pre.xml Edgar Link unprocessable
odyy_ex1006.htm Edgar Link pending
odyy_ex1007.htm Edgar Link pending
odyy_ex3101.htm Edgar Link pending
odyy_ex3102.htm Edgar Link pending
odyy_ex3201.htm Edgar Link pending
odyy_ex3202.htm Edgar Link pending
odyy_i10q-103122.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
odyy_i10q-103122_htm.xml Edgar Link completed